Skip to main content

Peer Review reports

From: Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024)

Original Submission
20 Feb 2025 Submitted Original manuscript
2 Mar 2025 Reviewed Reviewer Report
6 Mar 2025 Reviewed Reviewer Report
28 Mar 2025 Author responded Author comments - Xiaoling Wu
Resubmission - Version 2
28 Mar 2025 Submitted Manuscript version 2
31 Mar 2025 Author responded Author comments - Xiaoling Wu
Resubmission - Version 3
31 Mar 2025 Submitted Manuscript version 3
3 Apr 2025 Reviewed Reviewer Report
7 Apr 2025 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
8 Apr 2025 Editorially accepted
22 Apr 2025 Article published 10.1186/s40360-025-00920-4

You can find further information about peer review here.

Back to article page